[Etiotropic therapy of viral neuroinfections].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003851:Deoxyribonucleases / Q000627:therapeutic use; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000188:drug therapy*; D012260:Ribonucleases / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D007369:Interferon Inducers; D014765:Viral Vaccines; D007372:Interferons; D003851:Deoxyribonucleases; D012260:Ribonucleases
Etiotropnaia terapiia virusnykh neĭroinfektsiĭ.